Literature DB >> 9672359

Clostridium difficile colitis associated with treatment of Helicobacter pylori infection.

A Nawaz1, I Mohammed, K Ahsan, A Karakurum, C Hadjiyane, C Pellecchia.   

Abstract

Helicobacter pylori infection of the stomach is being detected and treated more often now than ever before. This is likely to result in an increase in complications such as antibiotic-associated diarrhea. However, there is no literature on the incidence of such diarrhea, particularly Clostridium difficile colitis, in patients treated for Helicobacter pylori infection. We report the case of a patient who developed Clostridium difficile colitis after treatment for Helicobacter pylori infection with metronidazole, amoxicillin, H2 blockers, and bismuth subsalicylate. This patient presented with severe diarrhea that responded to a course of metronidazole with rapid disappearance of symptoms. The incidence of Clostridium difficile colitis in patients treated for Helicobacter pylori infection has not been studied. This unique association, although not unexpected, has not yet been reported in the literature. The increasing number of patients being diagnosed and treated for this infection requires a heightened awareness on the part of physicians, to assure early diagnosis and treatment of this treatable, yet potentially dangerous, complication.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9672359     DOI: 10.1111/j.1572-0241.1998.00358.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  7 in total

1.  Refractory hypotension after bilateral nephrectomies in a Denys-Drash patient with phenylketonuria.

Authors:  Amanda B Hassinger; Sudha Garimella
Journal:  Pediatr Nephrol       Date:  2012-09-20       Impact factor: 3.714

Review 2.  Drug-induced diarrhoea.

Authors:  O Chassany; A Michaux; J F Bergmann
Journal:  Drug Saf       Date:  2000-01       Impact factor: 5.606

3.  Pseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradication.

Authors:  Anca Trifan; Irina Girleanu; Camelia Cojocariu; Catalin Sfarti; Ana Maria Singeap; Carmen Dorobat; Lucia Grigore; Carol Stanciu
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

4.  Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities.

Authors:  Douglas R Morgan; Javier Torres; Rachael Sexton; Rolando Herrero; Eduardo Salazar-Martínez; E Robert Greenberg; Luis Eduardo Bravo; Ricardo L Dominguez; Catterina Ferreccio; Eduardo C Lazcano-Ponce; Maria Mercedes Meza-Montenegro; Edgar M Peña; Rodolfo Peña; Pelayo Correa; María Elena Martínez; William D Chey; Manuel Valdivieso; Garnet L Anderson; Gary E Goodman; John J Crowley; Laurence H Baker
Journal:  JAMA       Date:  2013-02-13       Impact factor: 56.272

Review 5.  Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era.

Authors:  Geoffrey A Preidis; James Versalovic
Journal:  Gastroenterology       Date:  2009-05       Impact factor: 22.682

6.  Onset of Ulcerative Colitis after Helicobacter pylori Eradication Therapy: A Case Report.

Authors:  Mitsuro Chiba; Tsuyotoshi Tsuji; Kenichi Takahashi; Masafumi Komatsu; Takeshi Sugawara; Iwao Ono
Journal:  Perm J       Date:  2016-03-21

7.  Treatment of Helicobacter pylori Is Not Associated With Future Clostridium difficile Infection.

Authors:  Shria Kumar; David C Metz; David E Kaplan; David S Goldberg
Journal:  Am J Gastroenterol       Date:  2020-05       Impact factor: 12.045

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.